MSD K.K. has revamped its sales regime to better cater to regional healthcare needs by empowering local management teams amid Japan’s push to decentralize its healthcare policy, President Tony Alvarez revealed on September 4. While maintaining a therapeutic franchise system,…
To read the full story
Related Article
- MSD’s Januvia Logs 1st Sales Decline in Japan on Re-Pricing
September 5, 2014
BUSINESS
- Pfizer, ASKA to Co-Promote RSV Vaccine Abrysvo in Japan
March 9, 2026
- Sumitomo to Launch Post-Marketing Study for iPSC Therapy by Year-End
March 9, 2026
- Drug Pricing Reform Draws Sharp Industry Backlash in Jiho Poll
March 9, 2026
- Nitrosamine Detected in Nichi-Iko’s Tryptanol, No Need to Halt Prescriptions
March 9, 2026
- Towa Broadens Label for Tacrolimus in Cell Transplantation
March 9, 2026
I recently sat down with one of the leading medical directors in Japan to discuss the critical evolution of the medical science liaison (MSL) role.The MSL has transformed from a scientific resource into a strategic partner essential for successful product…





